MGMT and glioblastoma: Ex vivo treatment experiments carried out on two other MGMT promoter-methylated primary GBM cell cultures in our collection (GBM4 and GBM5) similarly detected expanded subclonal populations harboring deleterious C:G>T:A transitions in an NpCpT or NpCpC context in known cancer driver genes (Table 6).